Three IPOs worth Rs 3,300 crore are set to open for subscription between November 23 and 27. Integris Medtech and Foodlink F&B Holdings lead the mainboard offerings, while Shree Siddhivinayak Greentech Industries targets the SME segment. Investors also watch for the listing of Coal India subsidiary Mahanadi Coalfields on November 27.

The primary market is set for a busy week, with three IPOs expected to raise an estimated Rs 3,300 crore. Integris Medtech and Foodlink F&B Holdings will lead the mainboard offerings, while Shree Siddhivinayak Greentech Industries will tap the SME segment. Investors will also track the listing of Coal India subsidiary Mahanadi Coalfields and Crystal Crop Protection.

The primary market is gearing up for another busy week, with three initial public offerings (IPOs) involving an estimated Rs 3,300 crore in fundraising scheduled to open for subscription between November 23 and 27. The action will be led by two mainboard offerings, Integris Medtech and Foodlink F&B Holdings, while investors will also watch the stock market debut of Coal India subsidiary Mahanadi Coalfields.

Integris Medtech is preparing to launch an IPO estimated at Rs 3,000 crore, while Foodlink F&B Holdings will open an issue comprising a fresh offering worth Rs 192 crore and an offer for sale by existing shareholders. In the SME segment, Shree Siddhivinayak Greentech Industries will raise up to Rs 93.66 crore.

The combined fundraising estimate could change as the two mainboard companies are yet to finalise their pricing details. Meanwhile, Mahanadi Coalfields' Rs 8,981-crore IPO will close for subscription on Monday, November 23, ahead of its scheduled listing on Friday, November 27.

Here is a closer look at the IPO activity lined up for the week.

Integris Medtech IPO

Medical devices manufacturer Integris Medtech is preparing to launch an initial public offering estimated at Rs 3,000 crore, making it the largest new issue expected to open next week.

The company's IPO is scheduled to open for subscription on Friday, November 27, and close on Tuesday, December 1, according to a report by The Economic Times.

The offering will comprise a fresh issue of equity shares worth Rs 600 crore and an offer for sale of up to 1.08 crore shares by existing shareholders.

The company had earlier proposed raising Rs 925 crore through the fresh issue but subsequently reduced it to Rs 600 crore. The number of shares proposed to be sold through the OFS was also reduced.

The final issue size will depend on the price fixed for the shares offered by existing shareholders.

Integris Medtech is a Gurugram-based medical products and laboratory solutions company serving healthcare markets.

The IPO will provide existing shareholders an opportunity to sell part of their holdings, while the fresh issue will raise capital for the company.

The price band and minimum retail investment amount have yet to be announced.

Foodlink F&B Holdings IPO

Foodlink F&B Holdings will open its mainboard IPO for subscription on Thursday, November 26, with bidding scheduled to close on Monday, November 30.

The public issue comprises a fresh issue of equity shares aggregating to Rs 192 crore and an offer for sale of up to 88.35 lakh shares by existing shareholders.

The company has yet to announce its price band, which will determine the final size of the OFS and the overall issue.

Foodlink operates in the luxury food services segment, with businesses spanning event catering, casual dining restaurants, cloud kitchens, banquets and integrated food and beverage services.

Its restaurant and cloud kitchen portfolio includes brands such as India Bistro, China Bistro, Art of Dum and Glocal, with operations in India and the United Arab Emirates.

The company plans to use part of the proceeds from the fresh issue to establish a centralised kitchen, develop two new banquets and expand its restaurant operations.

According to its offer documents, Foodlink intends to allocate Rs 21.3 crore towards a new centralised kitchen and Rs 41.5 crore towards two new banquet facilities.

For FY26, the company reported revenue from operations of Rs 567.50 crore.

However, it reported a loss of Rs 16.15 crore on revenue of Rs 219.8 crore during the six months ended September 2026.

Investors will watch the company's final valuation, profitability and expansion plans when the price band is announced.

Mahanadi Coalfields listing next week

Apart from the fresh IPO openings, investors will also closely track Mahanadi Coalfields, whose shares are scheduled to make their stock market debut on Friday, November 27.

The Coal India subsidiary launched its Rs 8,981.12-crore IPO on November 19, with the subscription window closing on Monday, November 23.

The issue is entirely an offer for sale of 66.18 crore equity shares by Coal India, meaning Mahanadi Coalfields will not receive any proceeds from the public offering. The basis of allotment is expected to be finalised on November 25, followed by the proposed listing on the BSE and NSE on November 27.

Mahanadi Coalfields is among India's largest coal producers and operates primarily in Odisha's Talcher and Ib Valley coalfields. Its market debut will be one of the key events for the primary market next week, given the size of the offering and investor interest in Coal India's listed subsidiaries.

Crystal Crop Protection, whose Rs 455.49-crore IPO closed on November 20, is also scheduled to list on November 26.

SME IPOs

In the SME segment, Shree Siddhivinayak Greentech Industries will launch its Rs 93.66-crore IPO on Wednesday, November 25. The issue will remain open for subscription until Friday, November 27, with a price band of Rs 130-142 per share.

The offering consists of a fresh issue of equity shares and is proposed to be listed on the NSE SME platform. Shree Siddhivinayak Greentech Industries operates in the agro-processing business, manufacturing jaggery powder, khandsari sugar and related sugarcane-based products.

Disclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser. Podishetti Akash and his 'relative(s)' (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclosureshere.